Pooled Phase 3 Trial Analysis Confirms Efficacy and Safety of Tesamorelin in HIV-Associated Abdominal Fat | RemedyX Labs Research Library

A research summary of Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in Human Immunodeficiency Virus-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Multicenter, Double-Blind Placebo-Controlled Phase 3 Trials with Safety Extension Data, examining pooled phase 3 trial analysis confirms efficacy and safety of tesamorelin in hiv-associated abdominal fat. Cited source and RUO context from RemedyX Labs.